Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating PotentialUNIONDALE, NY, ...

Using the iconPCR system, n6 presents enhancements in low-pass whole genome sequencing. This approach enables balanced, ...

Revvity, Inc. RVTY is slated to report third-quarter 2025 results on Oct. 27, before market open. In the last reported ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webinars presented every Wednesday for 8 weeks! At 7:45am PT meet our ...

Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic platform that can help close vaccination gaps and quickly detect ...

The "DiaSorin S.p.A. (DIA) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. DiaSorin's immunodiagnostic and molecular diagnostics offerings are integral ...

Molecular Instruments® and Abcam partner to announce plug-and-play HCR™ HiFi Encoder compatibility with Abcam’s primaries.

Ultima Genomics has transformed highly efficient, production-scale sequencing while reducing the sequencing cost per genome ...

Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.

The news reported that classes in public schools in the National Capital Region were suspended because of a rise in influenza-like illnesses (ILI). This was later followed by an announcement that the ...

The expansion of the HSV testing market is being fueled by a combination of increasing prevalence of HSV infections, ...